The solution structure and the mode of action of arenicin isoform 1, an antimicrobial peptide with a unique 18-residue loop structure, from the lugworm Arenicola marina were elucidated here. Arenicin folds into a two-stranded antiparallel β-sheet. It exhibits high antibacterial activity at 37 and 4
INTRODUCTION
Two isoforms of a new class of antibacterial cationic peptides, termed arenicins, have been isolated from the coelomocytes of the marine polychaeta lugworm, Arenicola marina [1] . The mature peptides consist of 21 amino acid residues comprising a disulfide bond and a unique 18-amino-acid-residue loop structure. They are rich in arginine and hydrophobic amino acid residues (tyrosine and tryptophan) and differ only by a single, conservative amino acid substitution (V10I). Both isoforms exhibit identical potent antimicrobial activity against Escherichia coli, Listeria monocytogenes and Candida albicans [1] . Due to their molecular size, net charge and origin, arenicins are classified as natural AMPs (antimicrobial peptides), also referred to as host defence peptides [2, 3] . This expanding group of peptides forms a part of the innate immune system of all animals. They are secreted by specific immune cells, such as neutrophils [4] , NK (natural killer) cells or coelomocytes [5] and are also found on exposed body surfaces, e.g. skin and lung, where they provide a first line of defence against invading pathogens [6] [7] [8] . These peptides display a highly diverse tertiary structure. Prominent examples are linear α-helical peptides such as magainins [9] and cecropins [10] , or β-sheet structures with a complex disulfide pattern, e.g. the defensins [4, 11] . The arenicin structure, however, appears to be unique. As arenicins bear a net positive charge (+ 6) in combination with a substantial number of hydrophobic amino acid residues, a membranolytic step involved in the killing of micro-organisms may be assumed. However, information on the arenicin-membrane interaction is incomplete and the mechanism of the antibiotic action remains elusive.
Here, we present a comprehensive study on the mode of action of this extraordinary peptide with a focus on Gramnegative bacteria. Using NMR spectroscopy, we elucidated the solution structure of arenicin isoform 1 (RWCVYAYVRVRGVL-VRYRRCW-CO 2 H), and investigated and visualized its interaction with viable bacteria possessing defined LPS (lipopolysaccharide) structures and with the corresponding reconstituted membrane mimetics. The present study included determination of the biological activity of arenicin, an ultrastructural analysis of arenicin-treated bacteria by AFM (atomic force microscopy) and electron microscopy, permeabilization of bacterial membranes, elucidation of the different steps of arenicin's membrane interaction, i.e. binding, insertion and permeabilization using FRET (Förster resonance energy transfer) spectroscopy, arenicinmediated dissipation of the membrane potential of liposomes and electrical measurements of arenicin-induced lesions in planar lipid bilayers.
EXPERIMENTAL Peptides, PLs (phospholipids) and reagents
Chemically synthesized arenicin (RWCVYAYVRVRGVLVR-YRRCW-CO 2 H) with a non-amidated C-terminus was purchased from Biosyntan (Berlin, Germany). The sequence is identical with that of arenicin isoform-1, which differs from isoform 2 by a single-amino-acid substitution (V10I), as previously identified [1] , and is referred to throughout the present paper as arenicin. The correct formation of the disulfide linkage (Cys 3 -Cys 20 ) of the synthetic peptide was confirmed by MS [kindly performed by Dr Christoph Gelhaus (Department of Zoophysiology, Zoological Institute, Christian-Albrechts-University, Kiel, Germany)]. Melittin was synthesized by solid-phase synthesis by Fmoc (fluoren-9-ylmethoxycarbonyl) chemistry and purified
Figure 1 Structures of arenicin and LPS
Ribbon representation of the three-dimensional structure (PDB ID 2JSB) (A) and the electrostatic potential map (B) of arenicin. Both structures are shown in an identical orientation. Positively charged regions are depicted in blue. Structures of LPS from the various deep-rough mutant bacterial strains used in the present study are illustrated schematically (C). LPS isolated from E. coli WBB01, S. enterica R595 and P. mirabilis R45 differ mainly in the degree of aminoarabinose (Ara4N) substitutions at 4 -and 1-phosphate of the diglucosamine backbone of the lipid A moiety (R1) and at the carboxy group of the first Kdo (3-deoxy-D-manno-oct-2-ulosonic acid) sugar (R2) [28] . The position of the Ara4N (4-amino-4-deoxy-L-arabinose) R1-substitution cannot be assigned to either phosphate group. Non-stoichiometric Ara4N substitutions of LPS and net charges are listed in (D).
by HPLC as described previously [12] . Asolectin and polymyxin B, in its sulfate salt form, were purchased from Sigma (Deisenhofen, Germany).
and L-α-phosphatidyl-DL-glycerol [PG (phosphatidylglycerol); chicken egg] were purchased from Avanti Polar Lipids (Alabaster, AL, U.S.A.). Lipids (purity > 99 %) were used without further purification. NBD-PE (7-nitrobenz-2-oxa-1,3-diazole-PE) and N-(lissamine rhodamine B sulfonyl)-PE (rhodamine-PE) were from Molecular Probes (Eugene, OR, U.S.A.). All other chemicals were of analytical grade and purchased from Merck (Darmstadt, Germany).
Bacteria and bacterial culture
The bacterial strains used were six Gram-negative and one Grampositive isolates: (i) deep-rough mutant strains with defined LPS Re structures (Figure 1 ): E. coli WBB01, Salmonella enterica serovar Minnesota R595, Proteus mirabilis R45, (ii) strains with the complete LPS core sugar (LPS Ra): E. coli A.T.C.C. 23716, S. enterica serovar Minnesota R60, (iii) E. coli K-12 strain D31, an ampicillin-and streptomycin-resistant strain, the LPS core of which lacks some glucose, galactose and rhamnose residues [13] , and (iv) a Gram-positive representative, Bacillus megaterium (A.T.C.C. 14581). Bacteria were grown overnight in LB (Luria-Bertani) medium with constant shaking at 37
• C and subsequently inoculated into the same medium and grown to mid-exponential phase.
LPS
Deep-rough type LPS was extracted from E. coli strain WBB01 grown at 37
• C by the phenol/chloroform/light petroleum method [14] , purified and freeze-dried.
NMR experiments and structure calculation
Arenicin (1.8 mg) was dissolved in 0.7 ml of water/ 2 H 2 O/ deuterated acetic acid (44:5:1, by vol.). Two-dimensional TOCSY [τ m (mixing time) = 75 ms] and NOESY (τ m = 150 ms) spectra with WATERGATE (water suppression by gradient-tailored excitation) solvent suppression were recorded on a Varian Inova 600 MHz spectrometer at 283.15 K. Hydrogen-bonding was evaluated using H-2 H exchange experiments. Hydrogen bonds were detected by recording one-dimensional 1 H spectra after dissolving 1.8 mg of arenicin in 2 H 2 O; hydrogen bonds were assigned only to amide protons that still were detectable after 16 h. The assignment of proton resonances was carried out using TOCSY and NOESY data. Interproton distance restraints were derived from the cross-peak intensities in the NOESY spectrum by 1/r 6 calibration. Additional distance restraints were added to represent the Cys 3 -Cys 20 disulfide bond and hydrogen bonds in the peptide backbone. Structure calculations were performed with the CYANA 2.1 program [15] , applying a simulated annealing-molecular dynamics protocol. A total of 500 structures were calculated and the ten structures with the lowest target function were chosen to represent the ensemble and to calculate the average structure. For graphical representation, the RIBBONS software and the GRASP software were used [16, 17] . 
Assay for haemolytic activity
A 20 µl portion of washed human erythrocytes (5 × 10 8 cells/ml) in 10 mM PBS (pH 7.4) was incubated with 80 µl of a peptide sample (arenicin, melittin or polymyxin B) in the same buffer for 30 min at 37 or 4
• C in a round-bottom microtitre plate (Nunclon Surface; Nunc, Roskilde, Denmark). After the incubation period, the plate was centrifuged at 1000 g for 10 min at 4
• C to remove intact erythrocytes, and the concentration of released Hb was measured in a microtitre plate reader at 405 nm (Rainbow; Tecan, Grödig/Salzburg, Austria) after 10-fold dilution of the supernatant. Haemolytic activity was expressed as percentage haemolysis {% haemolysis = [(A Sample -A buffer )/(A max -A buffer ) × 100], where A is absorbance}. Maximal lysis (A max ) was achieved by adding distilled water, instead of the peptide sample, to the cells. Results shown represent the means for at least two experiments, each performed in duplicate.
Assay for cytotoxic activity
The influence of peptides (arenicin or melittin) on the viability of human cells was determined by monitoring the increase in the fluorescence of alamarBlue (BioSource) caused by metabolically active cells only. Jurkat cells were grown in RPMI 1640 medium (Gibco BRL) supplemented with 10 % (v/v) fetal bovine serum (PAA Laboratories, Parkerford, PA, U.S.A.) at 37
• C and 5% CO 2 , washed twice with 20 mM Mes and 150 mM NaCl (pH 5.5) and resuspended in the same buffer. Cells (5 × 10 5 ; 40 µl) were added to 2-fold serial dilutions of the proteins in the same buffer (50 µl) in a precoated microtitre plate [0.1 % BSA (Sigma) at 20
• C for 10 min] and incubated at 37 • C and 5% CO 2 . After 30 min, 10 µl of alamarBlue (final concentration: 10 %) were added and the cells were incubated for a further 30 min. The increase in fluorescence was measured in the microtitre plate fluorescence spectrophotometer (Fluoroskan II; Labsystems, Milford, MA, U.S.A.) using a λ ex of 538 nm and a λ em of 590 nm. The fluorescence difference between Jurkat cells treated with 0.1 % Triton X-100 and cells treated with buffer only under the same conditions was taken as the value for 100 % cytotoxic activity. LD 50 (peptide concentration at which 50 % of the cells were killed) values were derived from dose-response curves. Each curve represents the means for two independent experiments, each performed in duplicate.
Assays for antibacterial activity

Determination of MIC (minimal inhibitory concentration) and MBC (minimal bactericidal concentration)
Peptides (arenicin, melittin or polymycin B) were dissolved in the indicated buffer (Table 1) . Each solution (180 µl) was pipetted into the first well of a microtitre plate. For a 2-fold serial dilution, 90 µl of each solution was transferred to the next well filled with the same volume of buffer. Subsequently, a suspension of exponential-phase bacteria in LB medium was added [10 µl, containing 10 4 cfu (colony-forming units)] to each peptide solution (90 µl). The plates were incubated overnight in a wet chamber at 37
• C (or 4 • C where indicated) with constant shaking and bacterial growth was monitored by measuring A 620 in a microtitre plate reader (Rainbow; Tecan, Crailsham, Germany). The MIC was defined as the lowest peptide concentration at which no bacterial growth was measurable. Portions of each well (10 µl) were diluted with buffer, plated out in duplicate on LB-agar plates and incubated overnight at 37
• C, and bacterial colonies were counted. The MBC was defined as the peptide concentration where no colony growth was observed. The values were expressed as the means for at least two independent experiments, each performed in duplicate, with a divergence of not more than one dilution step.
Time course of bacterial killing
Bacteria were grown to exponential phase, washed with 20 mM Hepes and 150 mM NaCl (pH 7.0) and adjusted to 10 6 cfu/ml in the same buffer. The bacterial suspension was diluted 10-fold in buffer, and peptide (or buffer as a control) was added to reach final concentrations of 1, 2 and 5 µM. This suspension (500 µl) was incubated at 37
• C and at indicated time points aliquots were plated on to LB-agar plates and bacterial colonies were counted. Each independent experiment was performed in duplicate.
AFM
Exponential-phase bacteria (2 × 10 8 cfu/ml E. coli WBB01 in 0.2 ml LB medium) were incubated alone (control) or with 10 µM arenicin at 37
• C for 30 min. The bacteria were then placed on mica, excess liquid was removed with filter paper and the bacteria were air-dried at room temperature (21
• C) for 24 h. Dried bacteria were rinsed in 3 ml of water and imaged with an atomic force microscope in air using an MFP-3D (Asylum Research, Santa Barbara, CA, U.S.A.). Imaging in air was performed with NSG11-B cantilever (k = 5.5 N/m; NT-MDT, Moscow, Russia) in AC (tapping) mode, using frequencies of approx. 150 kHz. The frequency was chosen to result in an amplitude 5 % lower than the amplitude at the resonance frequency. The set point was always adjusted to guarantee minimum forces were applied to the sample. Further image processing (flattening and plane fitting) was done with the MFP-3D software under IGOR Pro (Lake Oswego, OR, U.S.A.). Images shown are representative of the respective samples.
Electron microscopy
Transmission electron microscopy of E. coli WBB01 was performed as described previously in detail [12] . Images shown are representative of the respective samples.
SYTOX Green assay
Bacteria (E. coli K-12 strain D31 [13] ) with compromized membranes were detected by monitoring the fluorescence of the DNA-binding dye SYTOX Green (Invitrogen, Molecular Probes). Bacteria in mid-exponential phase were washed twice with and resuspended in 10 mM Hepes and 25 mM NaCl (pH 7.4). A flat-bottom 96-well microtitre plate (Sarstedt, Essen, Germany) was coated with 0.1 % BSA (A2153; Sigma) for 15 min prior to its use in the assay. Arenicin was 2-fold serially diluted in 10 mM Hepes and 25 mM NaCl (pH 7.4). Bacteria (1 × 10 5 cfu/50 µl) were incubated with the diluted peptide (25 µl) and 2 µM of the fluorescent dye SYTOX Green (25 µl; in 10 mM Hepes and 25 mM NaCl, pH 7.4) at 37
• C for 1 h. Permeabilization of the bacterial outer and/or cytoplasmic membrane allowed the dye to cross the membranes and to intercalate into the DNA. When excited at 495 nm, the binding of the dye to DNA resulted in an increase in emitted fluorescence at 538 nm, which was measured in a microtitre plate reader (Fluoroskan II; Labsystems). Membranepermeabilizing activity of the peptides was expressed as a percentage of permeabilized bacteria. For maximum permeabilization of the bacteria (100 % value), cells were incubated with 70 % (v/v) ethanol for 5 min. The values were expressed as the means for two independent experiments, each performed in duplicate.
CD spectroscopy
CD measurements were carried out on a Jasco J-720 spectropolarimeter (Japan Spectroscopic Co., Tokyo, Japan), calibrated according to [18] . CD spectrum measurement represents the average of at least three scans obtained by collecting data at 1 nm intervals with a bandwidth of 2 nm. The measurements were performed in 50 mM sodium phosphate buffer (pH 5.8) at 10
• C in a 1.0 cm tandem quartz cuvette. The two chambers of the tandem cuvette were filled with either the peptide solution or the liposome suspension. After recording the CD spectrum, the cuvette was shaken for 20 min in order to mix the peptide solution and liposome suspension and a second CD spectrum was recorded. The ratio of arenicin to PG was 0.85:1 (w/w).
FRET spectroscopy
Intercalation of arenicin into PL liposomes and LPS aggregates was determined, at the indicated temperatures, by FRET spectroscopy applied as a probe-dilution assay as described previously [19] . The peptide was added to the liposomes (suspended in 20 mM Hepes and 150 mM NaCl, pH 7.0), and intercalation was monitored as the increase in the quotient of the donor fluorescence intensity (I D ) at 531 nm divided by the acceptor intensity (I A ) at 593 nm (FRET signal) in a time-dependent manner. All measurements were performed at least twice with no major discrepancies. Representative curves are shown.
Assay for pore-forming activity
Pore-forming activity of arenicin was determined by measuring fluorimetrically the dissipation of a valinomycininduced membrane potential in asolectin liposomes [20] . The measurements were repeated eight times and a representative curve is shown.
Preparation of planar bilayers and electrical measurements
Planar lipid bilayers were prepared by the Montal-Mueller technique [21] as described previously in detail [22, 23] . For the reconstitution of the cytoplasmic membrane of human cells, instead of natural PC, DPhyPC was used to obtain greater stability of the membranes. The inner leaflet of the outer membrane of Gramnegative bacteria was reconstituted by a PL mixture consisting of PE, PG and diphosphatidylglycerol (molar proportion 81:17:2). In all experiments, the compartment to which peptide was added is named first (cis), and the compartment opposite to the addition (trans) was grounded. To be consistent with the literature, we used a negative sign for voltages if the potential applied to the ciscompartment was positive (i.e. reflecting a negative membrane potential inside the cell). All measurements were performed in 5 mM Hepes, 100 mM KCl and 5 mM MgCl 2 (pH 7.0) (specific electrical conductivity 17.2 mS/cm) at 37
• C. Representative current traces of at least five independent measurements are shown.
RESULTS
Solution structure of arenicin
In total, 194 distance restraints obtained by NMR spectroscopy were used to calculate the structure of arenicin. Figure 1A ). The strands of the β-sheet are connected by a type I β-turn. The surface of arenicin is amphiphilic, with distinct hydrophobic and hydrophilic areas.
The electrostatic-potential surface of the averaged arenicin structure reveals large hydrophobic areas separated by the positively charged arginine side chains ( Figure 1B) . Since the charged arginine side chains are highly mobile, this picture reflects only a static image of the charge distribution. However, this characteristic distribution of charged and hydrophobic areas is achieved by inserting a significant right-handed twist into the β-sheet structure, thus preventing an even charge distribution on the molecular surface. A comparison with the previously published structure of arenicin isoform 2 [24] revealed that, despite the right-handed twist, the β-sheet of arenicin isoform 2 is almost planar, whereas in the case of isoform 1 the β-sheet is bent. As a consequence, the overall shape of arenicin isoform 1 resembles a globular protein, thus contrasting with the elongated shape of isoform 2.
Cytotoxic activity
The cytotoxicity of arenicin and two reference peptides, i.e. bee venom melittin and polymyxin B, was monitored by measuring the release of Hb from freshly isolated human erythrocytes and by monitoring their effect on the metabolic activity of human Jurkat T-cells. Arenicin, in sharp contrast with the highly haemolytic melittin (LD 50 = 3-4 µM), appeared to be only moderately lytic with an LD 50 above 40 µM (35.5 % lysis at 30 µM). Notably, polymyxin B, despite its considerable hydrophobicity due to its alkyl chain, was completely non-haemolytic up to a concentration of 30 µM. Reduction of the incubation temperature from 37 to 4
• C did not abolish haemolysis, but led to a significantly reduced haemolytic effect of arenicin (9 % at 30 µM). By contrast, arenicin was substantially toxic to Jurkat cells. Killing was timeand concentration-dependent with an LD 50 of 4, 3.5 and 2.7 µM at 37
• C after 1, 2 and 3 h of incubation respectively. For comparison, melittin was effective against Jurkat cells with an LD 50 between 0.15 and 0.3 µM under the same conditions.
Antibacterial activity
We tested the antibacterial activities of the peptides under various buffer conditions using three deep-rough mutant (LPS Re chemotype) Gram-negative bacterial strains with well-defined LPS structures ( Figures 1C and 1D) , one of which we used in parallel for the preparation of model membranes to correlate biological with biophysical data. The bacterial panel included human pathogens and laboratory strains. From the perspective of drug development, it was chosen to reflect strains that are,
Figure 2 Time course of bacterial killing by arenicin
Bacteria (E. coli WBB01 and P. mirabilis R45) were incubated alone (control) and in the presence of three different concentrations of arenicin in buffer (20 mM Hepes and 150 mM NaCl, pH 7.0) at 37 • C. Viability of bacteria was assessed by plating out the bacterial suspensions at various time points and is presented as cfu (% of control)=(cfu peptide /cfu control ) × 100.
in general, more sensitive to the action of cationic peptides, i.e. E. coli WBB01, and strains that appear more resistant in particular to the action of polymyxin B, the prototype of a cationic peptidic antibiotic with potent activity against Gram-negative bacteria, i.e. P. mirabilis R45. In addition, we tested the antibacterial activity of the peptides against two rough mutant (LPS Ra chemotype) strains with LPS having complete core oligosaccharides.
Arenicin was active against all bacterial strains at a similar low concentration and, among the peptides tested, it was the most potent one against P. mirabilis (Table 1) .
Its activity was lower at a physiological salt concentration (150 mM) compared with buffer without any added salt. However, in buffers of various ionic strengths (150-500 mM), the activity of the peptide remained virtually constant. In particular, the MIC of arenicin against P. mirabilis was very low, even under conditions where polymyxin B was completely inactive. The further addition of a bivalent cation (i.e. Mg 2+ ) did not have any measurable effect. Notably, the arenicin concentration necessary to kill E. coli WBB01 and P. mirabilis R45 was the same at both 37 and 4
• C. The kinetics of bacterial killing by arenicin is rapid, as assessed by plating out bacterial suspensions and colony counting after incubation with the peptide (Figure 2 ). At 5 µM arenicin, complete killing of E. coli WBB01 was observed even after 5 min. It is worth mentioning that inhibitory and bactericidal concentrations that can be derived from these curves may differ from those shown in Table 1 , as here bacteria were incubated in buffer alone to avoid growth during the incubation period. However, a substantial replication of bacteria was observed overnight even in buffer alone. This is, in particular, reflected in the case of P. mirabilis in the presence of 1 µM peptide (Figure 2) .
Ultrastructure of E. coli WBB01
The effect of arenicin (10 µM) on bacteria (exemplified here for E. coli WBB01) was visualized by AFM and electron microscopy. For AFM measurements, bacteria were incubated with the peptide in LB medium. As depicted in Figure 3 , arenicin had a dramatic impact on the structural integrity of bacteria when compared with an untreated control. For electron microscopy, bacteria were incubated alone and in the presence of the peptide for 30 min at 37
• C in Hepes buffer (20 mM Hepes and 150 mM NaCl, pH 7.0) supplemented with 10 % LB medium (Figure 4 ). Under these conditions, 79 % of bacteria were killed. Apparent steps in arenicin-mediated killing of E. coli became visible at higher magnification ( Figure 4B) , beginning with the formation of membrane blebs, release and condensation of cytoplasmic material, detachment of the outer membrane from the plasma membrane and formation of electron-dense spots on the outer membrane. Finally, the cytoplasm completely disappeared and the bacteria were covered with the spots, which may represent aggregated LPS from the outer membrane. Interestingly, bacteria undergoing cell division always exhibited two cytoplasmclearing sites and the electron-dense spot formation was concentrated at the septum.
Permeabilization of bacterial membranes
As the observed ultrastructure of arenicin-treated bacteria strongly suggested a membranolytic step in the mode of action of this peptide, we investigated the uptake of a DNA-intercalating dye, SYTOX Green, by a suitable bacterial strain, i.e. E. coli D31, during incubation with arenicin. Dye uptake directly reflects membrane permeabilization, as an intact lipid bilayer is not permeable to SYTOX Green itself. In the case of Gramnegative bacteria, inner and outer membrane permeabilization is apparently necessary to accomplish dye uptake. Considerable dye uptake was detected even after 5 min of incubation of bacteria with the peptide (Figure 5 ). The MIC of arenicin for E. coli D31, measured in parallel under these conditions, was 0.125 µM. Arenicin was also capable of permeabilizing the plasma membrane of a Gram-positive bacterial strain, B. megaterium (results not shown).
CD
CD spectroscopy was used to study the conformation of arenicin bound to liposomes. Figure 6 shows the CD spectra of arenicin in the absence as well in the presence of PG liposomes. The CD spectrum of arenicin in solution shows the typical shape of a β-sheet peptide, with a positive absorption band at 230 nm and a negative absorption band at 216 nm. This shape is dramatically changed in the presence of PG liposomes. The overall shape of the spectrum is indicative of a helical conformation of the peptide, although the two minima (219 and 231 nm) of the spectra are shifted to a higher wavelength compared with a CD spectrum of a helical protein in solution (208 and 222 nm). This shift indicates that arenicin inserts into the hydrophobic core of the PG liposomes and thereby undergoes a conformational change.
Insertion into model membranes
We used FRET spectroscopy as a sensitive tool to detect the specific interaction of arenicin with pure PL and LPS bilayers. Binding and subsequent insertion of peptides into the lipid bilayer is assumed to result in an increase in membrane area and dilution of the fluorescent probe, resulting in an increase in the observed FRET signal. Liposomes composed of zwitterionic PC and negatively charged PG were chosen to mimic the plasma membranes of human cells and of bacteria respectively. Aggregates made of LPS Re purified from E. coli strain WBB01 were used as a mimetic of the Gram-negative outer membrane. At 37
• C, rapid intercalation of arenicin was observed in all types of model membranes (Figure 7 ). In the different lipid systems, the changes in the FRET signal cannot be compared directly due to different aggregate structures. However, different intercalation characteristics were observed at lower temperatures as compared with 37
• C for the various lipids. An enhanced intercalation of peptide was observed particularly into the LPS membrane, but also into the negatively charged PG membrane when compared with PC. By contrast, arenicin intercalation into zwitterionic PC liposomes was decreased at lower temperatures.
Permeabilization of model membranes
Addition of arenicin to asolectin liposomes, loaded with potassium and a fluorescent dye, led to the immediate dissipation of a valinomycin-induced membrane potential (Figure 8) , and was the first direct evidence for a pore-forming activity of the peptide. To further characterize the electrical and geometrical properties of the arenicin-induced membrane lesions or pores and to investigate the lipid specificity of the peptide-membrane interaction, we employed the Montal-Mueller planar lipid bilayer technique. This system allows the reconstitution of membranes with virtually any lipid composition, including symmetrical membranes of DPhyPC ( Figure 9A ) and a defined PL mixture mimicking roughly the plasma membrane of human cells and the cytoplasmic membrane of bacteria ( Figure 9B) . Moreover, the asymmetrical outer membrane of the envelope of Gram-negative bacteria, consisting of LPS on its outer leaflet and PL on its inner leaflet, could also be reconstituted ( Figure 9C ). On addition of arenicin to the cis side of a planar lipid bilayer and application of a negative transmembrane voltage, we observed spontaneous current fluctuations after a certain lag period. The fluctuations appeared and vanished in a co-operative manner and reached maximal conductivity levels of 4 nS and a lifetime of several microseconds. The accumulation of a number of lesions eventually led to a dramatic increase in current flow and the disruption of the membrane (arrows). Both conductivity and lifetime are indistinguishable in all three types of membranes, suggesting in all cases the formation of structurally heterogeneous lesions rather than defined pores. Representative current traces are shown in Figures 9(A)-9 (C).
DISCUSSION
Arenicins are remarkably active effectors molecules of the lugworm's immune system and exhibit a broad-spectrum antimicrobial activity [1] . These particular AMPs caught our attention because of their unique cysteine-bridged large loop structure. Mechanistic information about how this new class of AMPs interacts with and kills bacteria has not been published so far. Arenicin isoform 1, which we have studied here in detail, forms a stable tertiary structure in solution, which resembles that of 
Figure 6 CD spectroscopy
The CD spectrum of arenicin in 50 mM sodium phosphate buffer (pH 5.2) (solid line) and in the presence of PG liposomes (dashed line) is shown. isoform 2 [24] , although isoform 1 exhibits a more globular form when compared with the elongated structure of arenicin isoform 2. Detailed analyses of the structures revealed that the two isoforms do not differ significantly in their backbone-dihedral angles and that these are not responsible for the overall structural difference. The right-handed twist in one of the β-strands in arenicin isoform 1 is due to experimentally derived 1 H-1 H distances that have not been observed in isoform 2 [24] . In addition, the bend of the arenicin isoform 1 β-sheet originates from observed longrange side-chain contacts that also have not been described for isoform 2. The antiparallel β-sheet is twisted to expose an amphipathic surface. Other β-sheet AMPs, such as protegrin-1 and tachyplesin-1, adopt similar solution structures [25, 26] although the β-sheet of arenicin is much more extended and is not caged between two disulfide bonds. This is in contrast with most α-helical AMPs, which only adopt a defined secondary structure on interaction with membranes or membrane-mimetic environments [12, 27] . As arenicin is amphipathic and rich in arginine and hydrophobic amino acid residues, it is reasonable to suppose that disruption of the membrane is involved in killing of the bacteria. To address this hypothesis, we investigated its interactions with Gram-negative bacteria and model membranes. In our comprehensive studies on the antibacterial properties of arenicin, and the ultrastructural analyses of arenicin-treated E. coli revealed signs of cell envelope destruction. Accordingly, the permeabilization of both membranes of viable E. coli also occurred within minutes. No pronounced lipid specificity for intercalation and pore formation of arenicin in model membranes composed to mimic the respective biological targets (i.e. zwitterionic PC for the erythrocyte plasma membrane, negatively charged PG or a PL mixture of PG, diphosphatidylglycerol and of zwitterionic PE for the bacterial cytoplasmic membrane and of LPS for the outer membrane of Gram-negative bacteria, such as E. coli, S. enterica and P. mirabilis) was observed. This is in contrast with the situation with other AMPs, such as polymyxin B and human β-defensin 3 for which the LPS structure, in particular the distribution of negatively charged groups, was decisive for the antibacterial activity [23, 28] .
Arenicin-induced permeabilization of model membranes is accompanied by peptide intercalation into the bilayer and a transmembrane current flow characteristic of structurally heterogeneous lesions. At a first glance, the characteristics of the obtained current fluctuations in planar lipid bilayers may fit into the carpet model [29] , rather than to a barrel-stave pore with defined geometry [30] . However, in general this view may be oversimplified [31] .
How does the structure of arenicin fit into the experimentally observed characteristics of the membrane lesions? Oligomerization of β-sheet domains is well documented for bacterial pore-forming toxins, such as α-toxin from Staphylococcus aureus. However, membrane pores formed by these toxins have a highly ordered cylindrical geometry [32] . Apparently, arenicin undergoes a pronounced conformational change after insertion into a membrane. Since it is too short to span an entire bilayer, it may be speculated that membrane defects were only elicited in the cis monolayer, which could explain the heterogeneity of the observed lesions. Further studies will shed more light on this issue.
The concentration of arenicin which was effective in killing bacteria was similar to the concentration that induced measurable effects on the respective model membranes. Although this does not rule out potential intracellular targets, it implies that membrane interaction, if it is not the lethal event itself, is at least an essential step in bacterial killing. This is in concordance with previous results, where we have shown that the interaction of various AMPs with model membranes with lipid compositions resembling those of different target cells reflected their biological activity [12, 23, 33] .
The focus of the present study is the interaction of arenicin with Gram-negative bacteria and respective biomembrane mimetics. However, we would expect comparable results with Grampositive bacteria and this has been proven exemplarily for membrane permeabilization of B. megaterium. The broader targetcell selectivity of arenicin compared with other AMPs, reflected in particular by considerable cytotoxicity towards Jurkat cells, may be attributed to the high salt concentration of the natural habitat of the lugworm. As the selectivity of peptides is mainly based on electrostatic interactions of the cationic peptide with the negatively charged bacterial surface [33, 34] , this interaction is impaired at the high salt concentration found in sea water. Thus a more pronounced hydrophobic interaction, which is presumably responsible for cytotoxicity, is necessary in this case to guarantee a potent antimicrobial activity. The evolutionary selection of arginine residues instead of lysine residues may also be an adaptation to high salt environment. It has been recently published that a lysine derivative of human α-defensin-1 is much less active and has a higher sensitivity to increasing salt concentration than the arginine-containing wild-type molecule [35] .
In summary, we have elucidated the structure and mode of action of arenicin isoform 1, a representative of a new class of AMPs. The peptide folds into a defined β-sheet tertiary structure and permeabilizes bacterial membranes, which is a key step in bacterial killing. Its potent activity against polymyxin Bresistant P. mirabilis, even at high ionic strength, its short length and disulfide-bond-stabilized tertiary structure make arenicin a particularly interesting antimicrobial compound and a lead structure for antibiotic drug development.
